Published in Open Dent J on January 22, 2008
Minocycline: far beyond an antibiotic. Br J Pharmacol (2013) 1.59
Periodontal disease: the influence of metabolic syndrome. Nutr Metab (Lond) (2012) 1.22
Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. Clin Infect Dis (2012) 1.12
Triple antibiotic paste in root canal therapy. J Pharm Bioallied Sci (2012) 1.02
Oxidative stress induced mechanisms in the progression of periodontal diseases and cancer: a common approach to redox homeostasis? Cancers (Basel) (2010) 0.87
Improvement of functional recovery of donor heart following cold static storage with doxycycline cardioplegia. Cardiovasc Toxicol (2014) 0.83
Glycation and oxidative stress in the failure of dental implants: a case series. BMC Res Notes (2013) 0.82
Evaluation of Antimicrobial Effects of Different Concentrations of Triple Antibiotic Paste on Mature Biofilm of Enterococcus faecalis. J Dent Res Dent Clin Dent Prospects (2015) 0.81
Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management? Open Access Rheumatol (2010) 0.79
Silica/quercetin sol-gel hybrids as antioxidant dental implant materials. Sci Technol Adv Mater (2015) 0.78
A histomorphometric study of the effect of doxycycline and erythromycin on bone formation in dental alveolar socket of rat. Adv Biomed Res (2015) 0.76
Minocycline treatment suppresses juvenile development and growth by attenuating insulin/TOR signaling in Drosophila animal model. Sci Rep (2017) 0.75
Minocycline promotes the generation of dendritic cells with regulatory properties. Oncotarget (2016) 0.75
Metabolic syndrome in schizophrenia: theoretical, clinical and translational perspectives. Indian J Psychol Med (2013) 0.75
Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax (2000) 9.36
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation (2002) 6.26
The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr (2006) 4.35
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res (2004) 4.00
Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol (1998) 3.12
Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol (2006) 3.02
Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res (1998) 3.01
Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications (2005) 2.85
Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation (2005) 2.36
Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr (2006) 2.36
Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol (2002) 2.34
Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes (2005) 2.28
Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci (2004) 2.08
Diabetes mellitus and periodontal disease. Periodontol 2000 (2007) 1.82
Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract (2006) 1.78
Effect of non-surgical periodontal treatment with or without doxycycline on the periodontium of type 1 diabetic patients. J Clin Periodontol (2005) 1.69
Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial. J Periodontol (2004) 1.62
Intensifying insulin therapy in patients with type 2 diabetes mellitus. Am J Med (2005) 1.60
The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol (1998) 1.56
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem (2005) 1.54
Microbial mechanisms in the pathogenesis of destructive periodontal diseases: a critical assessment. J Periodontal Res (1991) 1.54
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
Host response modulation in the management of periodontal diseases. J Clin Periodontol (2005) 1.47
Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 (2007) 1.44
Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res (1998) 1.39
Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol (1986) 1.38
Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol (2003) 1.37
Tobacco smoking and chronic destructive periodontal disease. Odontology (2004) 1.33
Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett (2005) 1.31
Validation of smoking status in clinical research into inflammatory periodontal disease. J Clin Periodontol (2001) 1.29
Obesity and periodontal disease. Periodontol 2000 (2007) 1.28
Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury. Am J Physiol Renal Physiol (2004) 1.25
Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int (2005) 1.23
Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg (1998) 1.21
Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res (2005) 1.21
The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis (2005) 1.21
Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci (2000) 1.19
Metabolic disorders related to obesity and periodontal disease. Periodontol 2000 (2007) 1.15
Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers. J Periodontol (2005) 1.12
The Ginkgo biloba extract EGb761 reduces stress sensitivity, ROS accumulation and expression of catalase and glutathione S-transferase 4 in Caenorhabditis elegans. Pharmacol Res (2006) 1.12
Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model. Shock (2005) 1.09
Chemical and biological dynamics of tetracyclines. Adv Dent Res (1998) 1.08
Periodontal inflammation and insulin resistance--lessons from obesity. J Dent Res (2001) 1.06
Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chemother (2003) 1.05
Doxycycline modulates nitric oxide production in murine lung epithelial cells. J Immunol (2006) 1.05
Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition. Mol Cell Biochem (2005) 1.05
Biological foundation for periodontitis as a potential risk factor for atherosclerosis. J Periodontal Res (2005) 1.04
Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J Clin Periodontol (2005) 1.03
Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J Periodontol (2004) 1.02
Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob Agents Chemother (1997) 1.01
Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration. Neurochem Int (2006) 1.01
Prevalence of systemic diseases in Brisbane general and periodontal practice patients. Aust Dent J (2004) 0.99
Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease. Neuroscience (2006) 0.99
Anti-inflammatory activity of tetracyclines. Dermatol Clin (2007) 0.98
Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol (2005) 0.97
Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats: effects on matrix metalloproteinase-2, membrane type 1 matrix metalloproteinase, and laminin-5 gamma2-chain. Wound Repair Regen (2002) 0.94
Clinical relevance of adjunctive minocycline microspheres in patients with chronic periodontitis: secondary analysis of a phase 3 trial. J Periodontol (2004) 0.93
Minocycline and cytoprotection: shedding new light on a shadowy controversy. Curr Drug Deliv (2007) 0.92
Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone (2004) 0.91
Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study. J Clin Pharm Ther (2007) 0.91
Oxidant/antioxidant interactions of nicotine, Coenzyme Q10, Pycnogenol and phytoestrogens in oral periosteal fibroblasts and MG63 osteoblasts. Steroids (2006) 0.90
Antimicrobial therapy using a local drug delivery system (Arestin) in the treatment of peri-implantitis. I: Microbiological outcomes. Clin Oral Implants Res (2006) 0.90
Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart. Mol Cell Biochem (2006) 0.90
Controlled-delivery chlorhexidine chip versus amoxicillin/metronidazole as adjunctive antimicrobial therapy for generalized aggressive periodontitis: a randomized controlled clinical trial. J Clin Periodontol (2007) 0.90
Protective effects of grape seed proanthocyanidins against oxidative stress induced by lipopolysaccharides of periodontopathogens. J Periodontol (2006) 0.89
Therapy with adjunctive doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis. J Clin Periodontol (2004) 0.88
Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol (2005) 0.88
Oral infections and systemic diseases. Dent Clin North Am (2003) 0.88
Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitis. J Periodontal Res (2005) 0.87
Hormone mediation of immune responses in the progression of diabetes, rheumatoid arthritis and periodontal diseases. Curr Drug Targets Immune Endocr Metabol Disord (2002) 0.87
Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability. Biochem Pharmacol (2003) 0.87
The relationship between tomato intake and congestive heart failure risk in periodontitis subjects. J Clin Periodontol (2004) 0.87
Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated C-reactive protein levels. Am Heart J (2004) 0.86
Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions. Front Biosci (2006) 0.86
A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats. J Periodontol (2001) 0.85
Periodontal diseases and rheumatoid arthritis: a coincident model for therapeutic intervention? Curr Drug Metab (2007) 0.85
The association of periodontal disease parameters with systemic medical conditions and tobacco use. J Clin Periodontol (2004) 0.84
Locally delivered doxycycline as an adjunctive therapy to scaling and root planing in the treatment of smokers: a 2-year follow-up. J Periodontol (2006) 0.83
Oxidative stress, nutrition and neutrogenomics in periodontal health and disease. Int J Dent Hyg (2006) 0.83
Ginkgo biloba extract protects against mercury(II)-induced oxidative tissue damage in rats. Food Chem Toxicol (2006) 0.83
Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochem Biophys Res Commun (1992) 0.83
Periodontal treatment by Arestin and its effects on glycemic control in type 1 diabetes patients. J Int Acad Periodontol (2004) 0.83
Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells. Arch Oral Biol (2006) 0.82
Periodontal treatment and its effects on glycemic control: a review of the evidence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.82
Antioxidant effects of glutathione and IGF in a hyperglycaemic cell culture model of fibroblasts: some actions of advanced glycaemic end products (AGE) and nicotine. Endocr Metab Immune Disord Drug Targets (2006) 0.82
Diagnosis and anti-infective therapy of periodontitis. Expert Rev Anti Infect Ther (2007) 0.80
Tetracycline protects myocardium against ischemic injury. Front Biosci (2005) 0.80
Effects of minocycline and doxycycline on cell survival and gene expression in human gingival and periodontal ligament cells. J Periodontal Res (2006) 0.80
Mechanical therapy with adjunctive minocycline microspheres reduces red-complex bacteria in smokers. J Periodontol (2007) 0.79
Systemic low-dose doxycycline and alendronate administration and serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats. J Periodontol (2005) 0.79
[Reactive oxygen species and antioxidant mechanisms in the pathogenesis of periodontitis]. Ann Acad Med Stetin (2004) 0.78
In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction. Am J Vet Res (2006) 0.76
Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis. J Periodontol (2004) 0.76
The use of doxycycline in periodontology. Histologic in vivo study on mice affected by diabetes mellitus. Minerva Stomatol (2006) 0.76
Confusion between definitive and exploratory clinical therapy trials: when to believe and when to question. J Periodontol (2004) 0.75